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article under the CC BY-NC-ND license (Abstract Background/purpose: Recurrent aphthous stomatitis (RAS) is a common oral
mucosal disease. Recently, oxidative stress has been thought to play a major role in the etio-
pathogenesis of RAS. The aim of this investigation was to compare the serum levels of an
important oxidant agent [malondialdehyde (MDA)] and nonenzymatic antioxidants [uric acid
(UA) and vitamins C and E] in patients with RAS versus healthy individuals.
Materials and methods: Ninety-seven patients with idiopathic minor RAS and 97 race-, age-,
and sex-matched healthy individuals were included in this study. All these individuals were
allocated to three groups: RAS patients in the active stage (Group A); the same RAS patients
in Group A in the remission stage (Group B); and healthy individuals without RAS (Group C).
The serum levels of MDA, UA, and vitamins C and E were measured by the spectrophotometric
method. Independent sample t test and paired t test were performed for statistical evaluation.
Results: Serum MDA level of Group A was significantly higher than that of Group B (PZ 0.040)
or Group C (P Z 0.011), whereas the serum level of vitamin E was significantly decreased in
Group A as compared with Group B (PZ 0.012) or Group C (PZ 0.001). No statistically signif-
icant differences were found between Group B and Group C in terms of MDA, UA, and vitamins
C and E serum levels (P > 0.05).
Conclusion: With the double-faced character of oxidant/antioxidant, UA and vitamin C may
not play a crucial role in the pathogenesis of RAS. However, MDA and vitamin E can be used
as indicators for RAS.
Copyright ª 2016, Association for Dental Sciences of the Republic of China. Published by
Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).of Stomatology, The Third Hospital of Hebei Medical University, 139 Zi-Qiang Road, Shijiazhuang,
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Recurrent aphthous stomatitis (RAS) is one of the most
common oral mucosal disorders with prevalence of 25% in
the general population,1 characterized by recurrent and
painful ulcers on nonkeratinized oral mucosa.2e4 Three
clinical types were classified as minor, major, and herpe-
tiform by Stanley in 1972.3 Minor RAS is the most common
form, affecting about 80% of RAS patients, and can heal
spontaneously within 10e14 days without scarring.4
To date, the exact etiology of RAS is still uncertain, but
several factors such as trauma, stress, allergies, genetics,
infection, and immunology have been implicated.2e5 All
these factors mentioned are thought to have the ability to
disturb the equilibrium of oxidant/antioxidant status and
lead to excessive free radical formation, which can lead to
mammalian cell damage through its damaging effects on
peroxidation of protein, lipid, and DNA.6 Malondialdehyde
(MDA) is the main product of lipid peroxidation and is used
commonly as an oxidative stress indicator.7 The human
body has its own innate free radical scavengers, which are
classified into enzymatic antioxidants and nonenzymatic
antioxidants. The latter includes glutathione, vitamins A,
C, and E, and uric acid (UA).8
According to our knowledge, there are only several ar-
ticles in the literature about the concentration of nonen-
zymatic antioxidants in RAS patients with active lesions,9,10
but no data concerning those in RAS patients in the remis-
sion stage. Therefore, the aim of the present study was to
evaluate the serum levels of MDA, UA, and vitamins C and E
in RAS patients in the remission stage, and compare them
with the same RAS patients in the active phase and healthy
individuals to find new information about RAS
etiopathology.
Materials and methods
Study population
The present study included 97 patients with RAS who were
admitted to the Department of Stomatology of The Third
Hospital of Hebei Medical University and 97 race-, age- and
sex-matched healthy individuals with no history of any
episodes of RAS. The diagnosis of RAS was based on typical
patients’ history and clinical findings. All patients were
evaluated by an expert in oral medicine during the study.
The protocol of this study was approved by the Ethics
Committee of Bethune International Peace Hospital (Pro-
tocol No. 2014-12-9) and informed consent was obtained
from each participant.
All RAS patients recruited in the study had at least three
recurrences of oral ulcer per year and all of them were
idiopathic minor aphthae. The patients were otherwise
healthy. The healthy controls did not have any RAS attacks
before the study or during their participation in the study.
The following routine laboratory tests were performed:
complete blood count, erythrocyte sedimentation rate,
fasting glucose, liver and kidney function tests, and mea-
surement of thyroid stimulating hormone, electrolytes,
calcium, phosphorus, globulin, albumin, serum iron,
vitamin B12, and folic acid. The participants with normalbiochemical analysis results mentioned above were
included in the study. Individuals with any known history of
systemic diseases, smoking habits, and alcohol abuse were
excluded from the study. None of the participants was
pregnant, nursing, or had any symptoms of active inflam-
mation, and none was under a therapeutic regimen of
immunomodulatory agents, steroids, multivitamins, or
other antioxidant supplements that could influence the
results of tests performed in this study for the previous
3 months.
There were three groups: Group A consisted of 97 pa-
tients with active lesions of RAS; Group B comprised the
same 97 individuals in Group A in the remission stage of the
disease; and Group C included 97 race-, age-, and sex-
matched healthy individuals without RAS disease.
Blood samples
Venous blood samples (5 mL) were drawn into vacutainers
without any anticoagulant in the early morning after at
least 8 hours overnight fasting. Samples were centrifuged
at 3000 g for 10 minutes at 4C to obtain serum and stored
at 80C until being analyzed at the same time.
Measurements
The serum levels of MDA, UA, and vitamins C and E were
determined with a spectrophotometer (Genesys 10 UV
Scanning UV/VIS Spectrophotometer; Shimadzu, Tokyo,
Japan) according to the manufacturer’s recommendations
of commercial colorimetric assay kits (MDA/UA/vitamin C/
vitamin E Detection Kit; Nanjing Jiancheng Bioengineering
Institute, Nanjing, China). The concentrations of MDA, UA,
vitamin C and vitamin E were expressed as nmol/mL, mg/L,
mg/mL, and mg/mL, respectively.
Statistical analysis
All values were expressed as mean  standard deviation.
Independent sample t test and paired t test were used to
compare those quantitative data of unpaired samples and
paired samples, respectively. Statistical analysis was per-
formed with SPSS version 19.0 statistical software package
(SPSS Inc., Chicago, IL, USA). A P value < 0.05 was accepted
to be statistically significant.
Results
Ninety-seven RAS patients (55 female and 42 male) with a
mean age of 31.4  6.2 years (range 17e42 years) and 97
healthy controls (55 female and 42 male) with a mean age
of 30.1  5.8 years (range 19e40 years) were included in
the present study. No significant difference was found be-
tween patients with RAS and healthy individuals in terms of
age (P Z 0.136).
The serum levels of MDA, UA, and vitamins C and E are
presented in Table 1. The serum MDA level of Group A was
significantly higher than that of Group B (P Z 0.040) or
Group C (P Z 0.011), whereas the serum level of vitamin E
was significantly decreased in Group A as compared with
Table 1 Serum levels of MDA, UA, and vitamins C and E in
RAS patients and control individuals.
Parameters Group A
(n Z 97)
(Active RAS)
Group B
(n Z 97)
(Remission RAS)
Group C
(n Z 97)
(Control)
MDA (nmol/mL) 5.7  1.8* 4.5  1.2 4.5  0.8
UA (mg/L) 61.4  19.7 66.4  20.8 60.8  10.1
vitamin C (mg/mL) 14.9  2.6 15.6  2.8 15.9  2.4
vitamin E (mg/mL) 6.7  2.5* 8.9  1.6 9.0  1.2
* Significant difference when compared with control group.
MDAZ malondialdehyde; RASZ recurrent aphthous stomatitis;
UA Z uric acid.
Patients with recurrent aphthous stomatitis 403Group B (PZ 0.012) or Group C (PZ 0.001). No significant
differences were found between Group B and Group C with
respect to serum MDA, UA, and vitamins C and E levels
(P Z 0.966, 0.282, 0.733, and 0.864, respectively). There
were no significant differences in serum vitamin C and UA
levels between Group A and Group B (PZ 0.651 and 0.489,
respectively) or between Group A and Group C (P Z 0.313
and 0.894, respectively).
Discussion
In the present study, the serum levels of MDA and some
nonenzymatic antioxidants (UA and vitamins C and E) were
investigated in RAS patients with active lesions, the same
RAS patients in the remission stage, and healthy in-
dividuals. To the best of our knowledge, there are no pre-
vious reports concerning the above indicators in RAS
patients in the remission stage.
MDA is an important reactive carbon compound, which is
generated during the disintegration of lipid peroxides, and
is one of the most frequently used indicators of lipid per-
oxidation.9 As an end-product of peroxidation of membrane
lipids, excessive MDA has a toxic effect that leads to
changes in proteins, modification of amino-acid chains, and
impairment of structure and function of cell membranes.11
In our study, a significantly increased serum MDA level was
found in Group A when compared with Group B or Group C,
which was in accordance with previous studies.7,9,12 How-
ever, there was no significant difference between Group B
and Group C, which indicated that the antioxidative ability
of the organism was elevated for the reason of the self-
regulation mechanism, and the balance of oxidant/antiox-
idant systems was recovered in RAS patients in the remis-
sion stage.
As a final oxidation product of purine nucleotides, UA is a
powerful scavenger of free radicals in plasma.13 However,
the antioxidant effects of UA are manifested only in the
hydrophilic environment of biological fluids. With the hy-
drophobic environment created by lipids, UA may become a
prooxidant by forming free radicals in reactions with other
oxidants, and even could be converted into an oxidant by
oxidized lipids.14 In this study, there was no significant
difference in serum UA level between any two groups,
which may be due to the oxidant/antioxidant paradox of
UA, which indicates that UA may not play a role in the
etiology of RAS.Vitamin E (a-tocopherol) is a major lipid antioxidant in
the membranes of cells and subcellular organelles. It can
react directly with free radicals and interrupt lipid perox-
idation by scavenging the thiobarbituric acid reactive sub-
stances.15 Vitamin C (ascorbic acid) is an important water-
soluble vitamin and has a synergistic effect with vitamin E,
which can reduce the tocopheroxyl radical, an oxidized
form of a-tocopherol, back to a-tocopherol.16 It is not only
a potent antioxidant against free radicals, but also has
prooxidant activity as a result of the Fenton reaction; a
process in which free radicals are formed.17 The results
reported about the serum levels of vitamins in RAS patients
with active lesions were inconsistent. Decreased serum
levels of vitamins A, C, and E in RAS patients with active
lesion were demonstrated by Saral et al,9 whereas a
converse conclusion was observed by Khademi et al,10 who
detected no significant differences in vitamins between RAS
patients with active lesions and healthy controls. In the
current study, the minimum serum vitamin E level was in
Group A, which indicated that there was a deficiency of
vitamin E during the active phase of RAS. However, there
was no significant difference in serum vitamin C level be-
tween any two groups, which may be explained by the
double-faced character of vitamin C.
There were two limitations to the current study. First,
the age of the participants was low, which may have been
due to the frequent occurrence of minor RAS in young
adults. Second, disease severity was not considered. As the
patients with major and herpetiform RAS were excluded, it
is uncertain whether the current results obtained would be
the same with different types of RAS patients. Future
studies with a larger number of patients should be per-
formed to clarify this question.
In conclusion, the elevated serum MDA level and
decreased vitamin E level in RAS patients with active le-
sions indicate that there is increased oxidative stress.
Moreover, there were no significant differences between
RAS patients in the remission stage and healthy individuals
with regards to the parameters investigated in this study,
indicating that the balance of oxidant/antioxidant systems
is recovered in the remission stage of RAS.
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